 |
G17DT Immunogen |
|---|---|
| Trade Name | Gastrimmune(Tm) |
| Orphan Indication | Adenocarcinoma of the pancreas |
| USA Market Approval | USA |
| USA Designation Date | 2002-07-10 00:00:00 |
| Sponsor | Cancer Advances, Inc.;Westpark Corporate Center, Suite 210;Durham, North Carolina, 27713 |
